© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
270175 |
As an accredited 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
I’ve spent years in chemical labs, working late into the night with flasks, solvents, and compounds like this one. It’s funny—sometimes the longest, most complicated names settle into your daily vocabulary and become your closest partners, like 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole. Despite the tongue-twister of a name, this is a molecule with real significance for anyone knee-deep in organic synthesis and experimental medicine.
What’s different about it? Take a close look at the structure. Adding a hydroxymethyl group to a benzimidazole skeleton tweaks both the solubility and reactivity, and the bromine atom sitting at the 5-position opens up routes for substitution or activation in multi-step chemical syntheses. Chemists gravitate toward molecules like this when they are hunting for precursors, intermediates, or fine-tuned ligands for pharmaceutical exploration.
Compared to the swarm of benzimidazole derivatives on the market, this compound brings a remarkable degree of functionalization. The hydroxymethyl side chain helps modulate hydrogen bonding, and having a bromine at the “sweet spot”—the 5-position—means you can introduce more groups via classic approaches like palladium-catalyzed cross-coupling. Researchers with a drive to explore kinase inhibition, DNA binding, or antimicrobial activity reach for derivatives much like this one to expand their molecular libraries.
Years back, I helped set up a project exploring DNA-intercalating agents. In those early days, choices for benzimidazole starting materials were slim. Most were either unsubstituted or had groups at the “wrong” positions, forcing one to spend extra time tweaking them before the core experiments could even begin. Chemistry moves fast now. The availability of 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole changes that playing field because you have a substrate ready to respond to many manipulations, not just one or two.
For researchers diving into medicinal chemistry or even fluorescent probe design, the combination of a hydroxymethyl group and a bromine atom offers a platform for tagging, extending, or further derivatizing the benzimidazole ring. In practice, you see this compound come up in search results when teams are optimizing molecules for enzyme targeting or developing new scaffold libraries for small-molecule screens.
Medicinal chemistry departments use it to attach peptides, sugars, or imaging agents. In one series of experiments, a team may start with 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole and rapidly build a set of new analogs, some of which make it to enzymatic screens or antimicrobial assays. This kind of flexibility cuts down not just on synthetic steps, but also on cost and waste. That’s a real edge for grant-driven research where every dollar and every extra day counts.
There’s little room for compromise when it comes to chemical quality. Low-purity compounds mean disappointing reaction yields or false negatives in bioassays. For a sensitive intermediate like this one, labs expect a product with clearly defined specifications, such as melting point range, moisture content, and impurity thresholds. Samples fresh from the bottle should show a crisp NMR spectrum, a narrow HPLC peak—otherwise, synthetic plans stall out.
Some suppliers concentrate on keeping degradation at bay during storage and shipping. 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole doesn’t tolerate high moisture or extended exposure to light, so manufacturers use specialized containers and insert desiccants. Research teams value this attention to detail because it means weighing out only what you need, confident that the rest will remain active and unspoiled for later work.
I’ve seen the disappointment—the trickle of brown color or unexpected mass peaks on analysis—when a bottle of benzimidazole derivative takes a hit from bad capping or a humid bench. Labs that invest in airtight storage and cold-chain shipping save themselves heartache and extra troubleshooting. Years of research really have driven home the principle: quality of starting materials makes or breaks the reliability of your downstream results.
Chemical research happens at the intersection of curiosity and caution. Handling a halogenated benzimidazole brings with it the same obligations as any reactive aromatic: take stock of safety data, use gloves, work in a fume hood, minimize skin and respiratory exposure. The bromine substituent, while a gateway for chemistry, isn’t benign when mishandled.
I've watched young researchers learn hard lessons in caution, and I've dealt with situations where gloves and goggles made all the difference between a routine day and an incident report. Sourcing the compound from validated suppliers, relying on clear labeling and transparent documentation of batch history—all these matter when safety is on the line. Risk management, in my opinion, isn’t just a paperwork burden; it’s the difference between a thriving lab and a liability.
In my experience, most benzimidazole derivatives come in a few broad flavors: either simple ones like benzimidazole or 5-bromobenzimidazole, with little functionalization, or overly complicated variants with bulky groups that reduce solubility. This molecule slots into a sweet spot. The hydroxymethyl group mediates solubility across a range of solvents—ethyl acetate, DMSO, even water for short preps. It doesn’t gum up glassware or form stubborn residues.
Comparing this to 5-bromobenzimidazole without the hydroxymethyl, you lose reactivity. The methylol functionality gives a ready “handle” for attaching new chemical groups or linking onto biomolecules—think beads for protein pulldown experiments or fluorescent tags for imaging. In contrast, plain benzimidazole derivatives often call for introduction of a new functional group from scratch, taking extra steps and lowering overall efficiency.
Reliability earns trust. Academic labs, startups, and pharmaceutical giants all look for the same thing: a bottle of 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole that performs the same way each time. Irregular batch-to-batch quality leads to unrepeatable reaction yields or inconsistent biological results, and the wasted money and effort can add up quickly.
Several major chemical suppliers have learned to document batch results, NMR and HPLC data, and keep buyers informed about any lot-to-lot variations. Open communication and transparency from the manufacturer allow a seamless fit into demanding synthetic plans. I remember more than one Monday morning spent troubleshooting a failed sequence, only to realize the impurity profile of a new batch was the hidden culprit. That lesson doesn’t fade with time.
Certainty in starting materials builds confidence and protects investment. An established supply chain also covers for disaster mitigation—no one wants to lose weeks waiting for an emergency re-stock, especially when a paper deadline or a clinical milestone sits looming overhead.
Not every supplier hits the mark. Ask around, and you’ll hear about delayed shipments, incomplete test data, and storage instructions buried at the back of a PDF. For 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole, as with other specialty intermediates, clear and upfront communication about expiration, preferred storage, and recent stability results should be the standard.
I once managed an order where the material arrived with no CoA—no real purity or moisture information. We ended up bench-testing every vial. A wasted week, frankly. Chemical vendors who put as much effort into handling and packaging as they do into their synthetic chemistry set themselves apart.
Customers and researchers value the chance to ask questions about new analytical data, stability, and alternative packaging sizes. Some labs want 50 milligram samples for early studies, others need multi-gram lots for scale-up. Vendors who stay flexible and engaged will always win more trust.
I spend a good deal of time reading reproducibility studies and industry roadmaps. One thing is clear: reproducible research starts with solid starting materials. 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole gives researchers an adaptable platform, but that alone isn’t enough. What’s needed is greater visibility into quality standards and smarter logistics.
Bringing down barriers between manufacturers, distributors, and end-users guarantees better feedback loops and fewer surprises at the bench. For years, research communities have called for easy-to-use digital tracking for chemical purchases, real-time notification of recalls, and streamlined documentation of purity.
Some industry groups work on standardized digital CoAs—documents that travel electronically with every order and go straight into laboratory management systems. That makes tracking purity, lot changes, and synthesis records much easier. With investments in these tracking systems, research teams cut down on wasted effort and bolster the reliability of their data.
Many of the key advances in pharmaceutical and life science research come from picking just the right functional group on a scaffold. With its dual reactivity, this compound fits modern research needs—it’s more than just a stepping stone on a synthetic map. New kinase inhibitors, small-molecule probes, and diagnostic labels all use building blocks like this to move from concept to real pipeline candidates.
The benzimidazole core attracts attention from medicinal chemists because of its prevalence in bioactive molecules, with derivatives already showing antitumor, antiviral, and antibacterial profiles. The specific twist added by hydroxymethyl and bromo substitutions means researchers can push boundaries in chemical biology—linkers for protein labeling, small-molecule binders, even candidates for next-generation imaging tools.
Real research stories bear this out. Colleagues in academic and clinical labs have described using 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole as a precursor for more complex probes, some of which went into high-content screening assays or advanced microscopy studies. The difference shows up in the tighter signal, cleaner images, and more decisive activity data for their targets.
No commentary on specialty chemicals can ignore their environmental footprint. Organic synthesis produces waste that needs responsible handling—halogenated byproducts, spent solvents, even trace reactants. Some production facilities have begun tackling green chemistry head-on, shifting toward lower-impact reagents, less toxic waste streams, and solvent minimization.
For a benzimidazole derivative bearing bromine, these practices matter doubly. Halogenated waste can become a significant liability in poorly managed settings. As buyers, professionals push their suppliers for details about waste treatment, closed-loop recycling, and sustainable packaging options. Progress, though uneven, can add up. Even something as simple as bottle recycling programs or biodegradable desiccants marks a step toward a less wasteful research environment.
With every new synthetic route or assay, research teams build on the reliability of their raw materials. Direct engagement with suppliers of 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole—whether by requesting purity data, clarifying origin, or coordinating shipment times—leads to more precise results.
I’ve come to see purchasing chemicals as a partnership, not a mere commercial transaction. Asking about analytical data, shipping policies, or batch consistency means fewer surprises. Many suppliers now have technical support professionals on call, people who understand not just sales but the science behind every bottle. Labs that build these relationships cut down on miscommunication and get extra problem-solving power when troubleshooting reactions.
Over the years, my approach to research has shifted. Time and again, results improve when my team sources high-grade reagents and insists on transparency from our vendors. I see the real cost of dubious starting materials in lost weeks and dead ends. For projects relying on subtle structure-activity changes, small shifts in compound quality directly impact the conclusions you can draw.
Many successful teams keep digital logs of each lot, along with corresponding control runs. They schedule regular conversations with suppliers, especially when trying out a new intermediate or scaling up a process. The payoff—reliable, repeatable results—forms the cornerstone of serious scientific progress.
Sitting in the lab, looking at bottles lined up on the shelf, I’m always struck by how a single well-made compound can open up new research paths. 2-(Hydroxymethyl)-5-Bromo-1H-Benzoimidazole isn’t merely another name in a catalog. With its unique structure, a blend of practical reactivity and chemical flexibility, and the right handling, it powers a wide variety of modern research projects. By prioritizing purity, transparency, and reliable partnerships, labs can amplify not just experimental success, but also creative drive—the real root of progress in chemistry and biomedicine.
